Detection of Rare Somatic GNAS mutation in mccune-albright syndrome using a novel peptide nucleic acid probe in a single tube

5Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

McCune-Albright syndrome (MAS) is characterized by the triad of precocious puberty, café au lait pigmentation, and polyostotic fibrous dysplasia (FD) of bone, and is caused by post-zygotic somatic mutations-R201H or R201C-in the guanine nucleotide binding protein, alpha stimulating (GNAS) gene. In the present study, a novel peptide nucleic acid (PNA) probe with fluorescent labeling was designed to detect trace amounts of somatic mutant GNAS in a single tube reaction. The method was applied to screen GNAS mutations in six patients with MAS/FD. The results showed that the PNA probe assay could detect low abundant mutants in 200-fold excess of wild-type alleles. The GNAS mutation was found in three patients with severe disease (MAS) by using the assay. The other three patients with mild disease (having only FD) showed a wild-type result. This study has provided a simple method to detect trace amounts of GNAS mutants with high sensitivity in large amounts of wild-type DNA.

Cite

CITATION STYLE

APA

Lo, F. S., Chen, T. L., & Chiou, C. C. (2017). Detection of Rare Somatic GNAS mutation in mccune-albright syndrome using a novel peptide nucleic acid probe in a single tube. Molecules, 22(11). https://doi.org/10.3390/molecules22111874

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free